581 related articles for article (PubMed ID: 32586877)
1. Treatment options in type-2 low asthma.
Hinks TSC; Levine SJ; Brusselle GG
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32586877
[TBL] [Abstract][Full Text] [Related]
2. Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma.
Trivedi A; Pavord ID; Castro M
Lancet Respir Med; 2016 Jul; 4(7):585-592. PubMed ID: 27230825
[TBL] [Abstract][Full Text] [Related]
3. Molecular Targets for Biological Therapies of Severe Asthma.
Pelaia C; Crimi C; Vatrella A; Tinello C; Terracciano R; Pelaia G
Front Immunol; 2020; 11():603312. PubMed ID: 33329598
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine in asthma: the role of bronchial thermoplasty.
Oberle AJ; Mathur P
Curr Opin Pulm Med; 2017 May; 23(3):254-260. PubMed ID: 28319473
[TBL] [Abstract][Full Text] [Related]
5. Reslizumab in the treatment of severe eosinophilic asthma: an update.
Walsh GM
Immunotherapy; 2018 Jun; 10(8):695-698. PubMed ID: 29554826
[TBL] [Abstract][Full Text] [Related]
6. Promises and challenges of biologics for severe asthma.
Tan R; Liew MF; Lim HF; Leung BP; Wong WSF
Biochem Pharmacol; 2020 Sep; 179():114012. PubMed ID: 32389637
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies for the treatment of refractory asthma.
Hambly N; Nair P
Curr Opin Pulm Med; 2014 Jan; 20(1):87-94. PubMed ID: 24275927
[TBL] [Abstract][Full Text] [Related]
8. Biological treatments for severe asthma: A major advance in asthma care.
Busse WW
Allergol Int; 2019 Apr; 68(2):158-166. PubMed ID: 30792118
[TBL] [Abstract][Full Text] [Related]
9. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
Chung KF
J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
[TBL] [Abstract][Full Text] [Related]
10. Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma.
Blaiss MS; Castro M; Chipps BE; Zitt M; Panettieri RA; Foggs MB
Ann Allergy Asthma Immunol; 2017 Dec; 119(6):533-540. PubMed ID: 29103801
[TBL] [Abstract][Full Text] [Related]
11. New Treatments for Asthma.
Huang J; Pansare M
Pediatr Clin North Am; 2019 Oct; 66(5):925-939. PubMed ID: 31466682
[TBL] [Abstract][Full Text] [Related]
12. Biological treatments for severe asthma.
Assaf SM; Hanania NA
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):379-386. PubMed ID: 31169594
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
Barnes PJ
J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
[TBL] [Abstract][Full Text] [Related]
14. Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent.
Krings JG; McGregor MC; Bacharier LB; Castro M
J Allergy Clin Immunol Pract; 2019; 7(5):1379-1392. PubMed ID: 31076056
[TBL] [Abstract][Full Text] [Related]
15. New Targeted Therapies for Uncontrolled Asthma.
Corren J
J Allergy Clin Immunol Pract; 2019; 7(5):1394-1403. PubMed ID: 31076057
[TBL] [Abstract][Full Text] [Related]
16. The Cytokines of Asthma.
Lambrecht BN; Hammad H; Fahy JV
Immunity; 2019 Apr; 50(4):975-991. PubMed ID: 30995510
[TBL] [Abstract][Full Text] [Related]
17. Immunologic mechanisms in asthma.
Boonpiyathad T; Sözener ZC; Satitsuksanoa P; Akdis CA
Semin Immunol; 2019 Dec; 46():101333. PubMed ID: 31703832
[TBL] [Abstract][Full Text] [Related]
18. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
19. Endotypes of severe allergic asthma patients who clinically benefit from anti-IgE therapy.
Huang YC; Weng CM; Lee MJ; Lin SM; Wang CH; Kuo HP
Clin Exp Allergy; 2019 Jan; 49(1):44-53. PubMed ID: 30107059
[TBL] [Abstract][Full Text] [Related]
20. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.
Parulekar AD; Kao CC; Diamant Z; Hanania NA
Curr Opin Pulm Med; 2018 Jan; 24(1):50-55. PubMed ID: 29036019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
